Jose Juvenal Linhares

Prof. Dr. Jose Juvenal Linhares

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2015 in Sao Paulo Medical Journal
Verified
Journal Article
Open access
PDF file
JLJose Juvenal Linhares
Jose Juvenal Linhares
BDBárbara De Araújo Lima Dutra
Bárbara De Araújo Lima Dutra
MPMaycon Fellipe Da Ponte
Maycon Fellipe Da Ponte
LTLuis Fernando Farah De Tofoli
Luis Fernando Farah De Tofoli
PTPriscila Campos Távora
Priscila Campos Távora
GAGuarany Mont'Alverne De Arruda
Guarany Mont'Alverne De Arruda
CONTEXT AND OBJECTIVE: This research project arose from a proposal made to the teachers by the students of a medical course at a federal university in Brazil, from their personal experiences regarding the skills and competencies that should be developed during the obstetrics and gynecology (OBG) stage of the internship. The objective here was to develop the matrix of skills necessary for training good general physicians in the medical course.DESIGN AND SETTING: Exploratory qualitative study conducted in a federal university in Brazil.METHODS: The basis for developing these competencies among OBG interns was "The Competency Matrix for Medical Internship" developed by Bollela and Machado. The instrument was presented to, analyzed by and modified by a set of OBG specialists, at two sessions.RESULTS: The specific competencies expected from students over the internship in OBG were framed within overall topics that had previously been determined and listed: healthcare, decision-making, communication and interpersonal relationships, management and organization of the Brazilian National Health System (Sistema Único de Saúde, SUS) and professionalism.CONCLUSIONS: A competency matrix that standardizes the minimum requirements that interns should be capable of putting into practice after concluding the OBG stage is a valuable tool for ensuring student performance and a fair and rigorous assessment for them, thereby seeking to train good general physicians who meet the community's needs.

19 September 2018 in Revista Brasileira de Ginecologia e Obstetrícia
Verified
Journal Article
Open access
PDF file
TFTadeu Rodriguez de Carvalho Pinheiro Filho
Tadeu Rodriguez de Carvalho Pinheiro Filho
VPVanessa Rocha Pessoa
Vanessa Rocha Pessoa
TLThaisa de Sousa Lima
Thaisa de Sousa Lima
MCMarcela Melo de Castro
Marcela Melo de Castro
JLJose Juvenal Linhares
Jose Juvenal Linhares
Objective To analyze the use of the measurement of uterine cervix length (MUCL) and the fetal fibronectin (fFN) rapid test as predictors of preterm delivery (PTD) in symptomatic pregnant women assisted at the Santa Casa de Misericórdia de Sobral Maternity Hospital. Methods This was a prospective and analytic study involving 53 parturients assisted between September of 2015 and July of 2016; the participants were between 24 and 34 weeks of gestational age (GA) and presented complaints related to preterm labor (PTL) prodromes. Vaginal secretion was collected for fFN testing, and the MUCL was obtained via transvaginal ultrasonography. Results A total of 58.49% of the subjects showed MUCL < 25 mm, and 41.51% were positive in the fFN rapid test. A total of 48 patients were followed-up until their delivery date, and 54.17% resulted in PTL. The relative risk (RR) for PTD in patients with MUCL < 25 mm was 1.83 (p = 0.09, 0.99–3.36, 95% confidence interval [CI]), with a mean time before delivery of 2.98 weeks. Based on fFN positive results, the RR was 3.50 (p = 0.002, 1.39–8.79, 95%CI) and the mean time until delivery was 1.94 weeks. The RR was 2.70 (p = 0.002, 1.08–6.72, 95%CI) when both tests were used. The RR of PTD within 48 hours, and 7 and 14 days were, respectively, 1.30 (p = 0.11, 95% CI 1.02–1.67), 1.43 (p = 0.12, 95% CI % 0.99–2.06), and 2.03 (p = 0.008, 95% CI 1.26–3.27), when based on the MUCL, and 1.75 (p = 0.0006, 95% CI 1.20–2.53), 2.88 (p = 0.0001, 95% CI, 1.57–5.31), and 3.57 (p = 0.0002, 95% CI 1.63–7.81) when based on positive fFN results. The RR at 48 hours and 7 and 14 days considering both tests was 1.74 (p = 0.0001, 95% CI 1.14–2.64), 2.22 (p = 0.0001, 95% CI 1.22–4.04), and 2.76 (p = 0.0002, 95% CI 1.27–5.96), respectively. Conclusion In symptomatic pregnant women, we concluded that the MUCL < 25 mm associated with positive fFN rapid test indicate increased the risk for PTD. Further studies with larger sample sizes could contribute in supporting the results presented in the current study.

4 July 2024 in SANARE - Revista de Políticas Públicas
Verified
Journal Article
Closed access
GAGuarany Montalverne de Arruda
Guarany Montalverne de Arruda
LSLailton Oliveira da Silva
Lailton Oliveira da Silva
LTLouhanna Pinheiro Rodrigues Teixeira
Louhanna Pinheiro Rodrigues Teixeira
ASANDERSON WEINY BARBALHO SILVA
ANDERSON WEINY BARBALHO SILVA
JCJosé Jackson Do Nascimento Costa
José Jackson Do Nascimento Costa
JLJose Juvenal Linhares
Jose Juvenal Linhares
O câncer de mama (CM) foi reconhecido como o tipo de câncer mais comum em mulheres. A incidência e a mortalidade por câncer vêm aumentando no mundo, em par te pelo envelhecimento, pelo crescimento populacional, como também pela mudança na distribuição e na prevalência dos fatores de r isco de câncer, especialmente aos associados com fatores genéticos. Descrever e caracterizar o perfil epidemiológico de pacientes com câncer de mama submetidas ao tratamento quimioterápico neoadjuvante no interior do Ceará. Foi realizado estudo observacional do tipo transversal com 40 pacientes do sexo feminino, que usaram os quimioterápicos de forma neoadjuvante. 50% das pacientes tinham 50 anos ou mais, não tinham histórico familiar de câncer, não eram tabagistas, tiveram sua menarca em 59% dos casos após os 12 anos (n =23). A raça mais prevalente foi a parda, presente em 87% (n = 34) e a idade do primeiro parto foi menor que 20 anos em 66,5% (n = 24). Sobre o estadiamento do câncer, a grande maior ia estavam no estágio III 62,5% (n =24), referente à tumoração, foi evidenciado que a maior ia dos tumores (53%) apresentava diâmetros menores que 5cm. Ressalta-se a necessidade de estratégias públicas em parceira com a iniciativa privada para aumentar o alcance do diagnóstico precoce do CM, com a finalidade de evitar desfechos clínicos negativos e possibilitar uma melhor qualidade de vida das pacientes.

20 December 2021 in Medicina (Ribeirão Preto)
Verified
Journal Article
Open access
PDF file
JLJose Juvenal Linhares
Jose Juvenal Linhares
CQClara dos Santos Queiroz
Clara dos Santos Queiroz
FSFrancisco de Assis e Silva
Francisco de Assis e Silva
MSMicaele Esloane Soares
Micaele Esloane Soares
JNJosé Urbano de Medeiros Neto
José Urbano de Medeiros Neto
PNPedro Gomes Cavalcante Neto
Pedro Gomes Cavalcante Neto
RESUMO: Os contraceptivos intrauterinos contendo levonorgestrel, Mirena®, amplamente utilizados na ginecologia contemporânea como método eficaz de contracepção e controle de distúrbios menstruais, mostrou reduzir as taxas de câncer de endométrio. Além disso, complicações como perfuração e migração são raras, exigindo intervenção rápida. Descrição: Dois casos atípicos acerca do uso de dispositivo intrauterino hormonal, o primeiro trata de migração do dispositivo para a cavidade abdominal, após 1 ano e 8 meses da inserção, sem perfuração, com retirada videolaparoscópica. O segundo é um caso de câncer primário de endométrio em paciente com 3 anos de uso de Mirena®. Discussão: A migração do dispositivo intrauterino é uma complicação rara, pouco relatada na literatura, a abordagem videolaparoscópica é a preferencial e foi realizada no caso em questão. O dispositivo intrauterino hormonal também está relacionado à diminuição das taxas de câncer de endométrio e, inclusive, é usado como método preventivo em mulheres de alto risco. Após revisão de literatura, apenas seis casos similares foram descritos. Conclusão: O dispositivo hormonal intrauterino, apesar de seguro, pode implicar apresentações raras, como migração e perfuração, que exigem conhecimento e agilidade da equipe profissional. O segundo caso apresentado é um evento raro, que faz atentar para mulheres com padrão hemorrágico incomum em uso do Mirena®.

24 September 2020 in Revista de Ciências Médicas e Biológicas
Verified
Journal Article
Closed access
PDF file
DBDiego de Aragão Bezerra De Aragão Bezerra
Diego de Aragão Bezerra De Aragão Bezerra
JLJose Juvenal Linhares
Jose Juvenal Linhares
ENEmmanuelle Coelho Noronha
Emmanuelle Coelho Noronha
KTKaio César Simiano Tavares
Kaio César Simiano Tavares
AAAndré Saraiva Leão Marcelo Antunes
André Saraiva Leão Marcelo Antunes
MMMarcos Vinícius Souza Marques
Marcos Vinícius Souza Marques
Introduction: breast cancer (BC) is the most common tumor and the leading cause of cancer-related death among the female populationworldwide. Polymorphisms genetics of ABCB1 gene contributed to breast cancer susceptibility and interindividual differences inchemotherapy response. Objectives: to evaluate the association between the ABCB1 C3435T gene polymorphism (SNPs) with theresponse to neoadjuvant chemotherapy in women with breast cancer. Methodology: this study included 32 female patients whoreceived neoadjuvant chemotherapy. The polymorphisms were genotyped through real-time allele-specific polymerase chain reaction(PCR). The statistical analysis was performed using the Fisher’s exact test or Pearson’s chi-square test in the Statistical Package forSocial Sciences (SPSS) version 20.0 software. Results: the genotypes found for the C3435T polymorphism were in Hardy-Weinbergequilibrium and their genotypic distributions were CC= 10 (31.1%), CT= 14 (43.8%), and TT= 08 (25.0%) with χ2: 0.86 and p-value >0.05. Allele frequencies were C = 0.54 and T = 0.46. There were no significant statistical differences between genotypes considering theresponse to neoadjuvant chemotherapy and immunohistochemistry; the presence of the T allele was associated with worsen axillarystatus response to neoadjuvant chemotherapy. Conclusion: no definite association between the presence of C3435T polymorphismand the response to neoadjuvant chemotherapy was observed. Further studies in Brazil involving larger samples will contribute tovalidating the results of this study.

7 April 2026 in Mastology
Verified
Journal Article
Open access
PDF file
ECEmmanuel Filizola Cavalcante
Emmanuel Filizola Cavalcante
JLJose Juvenal Linhares
Jose Juvenal Linhares
LRLuciana Gomes da Rocha
Luciana Gomes da Rocha
SOSilvando Carmo de Oliveira
Silvando Carmo de Oliveira
FMFernando Daniel de Oliveira Mayorga
Fernando Daniel de Oliveira Mayorga
Diane Isabelle Magno CavalcanteDiane Isabelle Magno Cavalcante
Diane Isabelle Magno Cavalcante
Introduction: Fine-needle aspiration or core needle biopsy guided by ultrasound of the axilla can provide crucial information for the treatment of breast cancer. Methods: This prospective phase 1 real-world study evaluated the effectiveness of the triple test, physical examination (PE), ultrasound (US), and ultrasound-guided fine-needle aspiration (USFNA) or ultrasound-guided core needle biopsy (USCNB) in predicting axillary metastases. It also explored the possibility of omitting axillary surgery based on negative results. The study included patients with high-penetrance mutations, ductal carcinoma in situ, or invasive breast cancer (cT1–4, axillary cN0–2), all of whom underwent aspiration or biopsy along with lymph node marking (using charcoal or clips), followed by sentinel lymph node biopsy and/or axillary dissection. Results: A total of 363 lymph nodes were dissected in 43 patients. The sensitivity of PE and US was 33.3% and 53.3%, respectively. When combining USFNA/USCNB with PE and US, sensitivity increased from 66.67% to 80%. Among patients with mutations or ductal carcinoma in situ or invasive cancer (cT1–4), when all three methods (PE, US, and USFNA/USCNB) were negative, the rate of positive lymph nodes was only 10%. Conclusions: Relying solely on PE, US, or USFNA/USCNB has limitations in detecting axillary metastases. Incorporating USFNA/USCNB significantly improved sensitivity and decreased false-negative rates. When all three methods were negative, the rate of axillary involvement was only 10%, indicating that axillary surgery could potentially be omitted. However, further studies are needed to validate these methods as reliable predictive tools for treatment decisions.